Canopy Growth Corporation · TSX:WEED
Canopy Growth — Investor Presentation (August 2018)
18 slides from Canopy Growth's investor presentation, August 2018
Slide 1: Driving the Global Cannabis Industry
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton, Founder, Chairman & Co-CEO August 2018
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “Forward-Looking State
Slide 3: Company Snapshot
Company Snapshot Operations in 11 countries on 5 continents Canopy Growth is a world-leading diversified 10 world-class production facilities in Canada cannabis company, offering distinct brands and ❖ Proven commercial scale operations curated cannabis varieties in dried, oil and capsule ❖ 2.4M sq.
Slide 4: TSX:WEED NYSE:CGC
TSX:WEED NYSE:CGC 4
Slide 5: The Legalization of Cannabis is Spreading Globally
The Legalization of Cannabis is Spreading Globally Medical & Adult-Use Legalized Medical Use Legalized In the Process of Legalizing Medical Use / Exploring Legalization 5
Slide 6: Cannabis – A New Global Market
Cannabis – A New Global Market 1 Source: Eight Capital, “The Value Case for Investing in the Cannabis Sector”. 2 Source: Deloitte, “Recreational Marijuana Insights and Opportunities”. 3 Source: Eight Capital, “The Value Case for Investing in the Cannabis Sector”. 6
Slide 7: Built on Brands
BUILT ON BRANDS The diverse brands “under the Canopy” allow us to effectively deploy brands that are targeted towards specific customer demographics, use occasions and product form factors MEDICAL ADULT – USE OWNED BRANDS AFFILIATE BRANDS RETAIL Maitri, Van der Pop, DOJA and Tokyo Smoke owned by Hik
Slide 8: Leading The Global Medical Cannabis Market
Leading The Global Medical Cannabis Market International Canadian Market Education Regulatory Research & Leader & Market & Innovation Development Development Medical therapy 85,000+ patients development Clinical trials IP protection 8
Slide 9: Leading The Global Medical Cannabis Market
Leading The Global Medical Cannabis Market 9
Slide 10: Canadian Regulated Recreational Market
Canadian Regulated Recreational Market $5B - $9B $? $9B $6B $5B Beer Wine Spirits Black Market* First Time Social Lubricants! Buyers Source: Deloitte, “Recreational Marijuana Insights and Opportunities”. 10 Source: Deloitte, “Recreational Marijuana Insights and Opportunities”.
Slide 11: Deep Channels Into Recreational Market
Deep Channels Into Recreational Market 8 Supply Agreements Signed To Date • 67,500+ kg/yr. • Other Negotiations Ongoing Province Supply2 36% AB QC 30,000 kg/yr., 1 yr. 12,000 kg/yr., 3 yrs. Share of Supply NL 8,000 kg/yr. , 2 yrs. Agreements Signed To Date1 MB 6,500 kg/yr. , 1 yr. BC 5,700 kg/yr., 1
Slide 12: Engaging Retail – Build Brand, Build Demand
Engaging Retail – Build Brand, Build Demand Brick & Mortar Online Government Private TBD Owned & Technology-enabled Sales Force 12
Slide 13: Hiku Acquisition – Complementary Brands and Retail Footprint
Hiku Acquisition – Complementary Brands and Retail Footprint1,2,3 Brick & Mortar Online 8 Government 5 15 Private TBD ADULT – USE BRANDS 1 Canopy Growth’s acquisition of Hiku is subject to approval by Hiku shareholders, shareholder vote scheduled to take place August 30, 2018 . 2, Maitri, Van der Po
Slide 14: Cannabis – A Potentially Disruptive Ingredient
Cannabis – A Potentially Disruptive Ingredient NO ALCOHOL HAPPY WAISTLINE Cannabis-based beverage development collaboration* NO HANGOVER HAPPY LIVER $445M investment1 1) Investment made by Canadian subsidiary., includes $245M investment that closed on November 2, 2017 and $200M investment in 14 fina
Slide 15: Management Team
Management Team Bruce Linton Mark Zekulin Tim Saunders Dr. Mark Ware Chairman & CEO President & Co-CEO EVP & Chief Financial Officer Chief Medical Officer 15
Slide 16: Management Team
Management Team Phil Shaer Amanda Daley Rade Kovacevic Dave Bigioni Chief Legal Officer VP, Medical SVP & Managing Director, Chief Marketing Officer Canada 16
Slide 17: Bruce Linton
Bruce Linton Founder, Chairman & CEO bruce@canopygrowth.com 17
Slide 18: Performance Highlights
Performance Highlights Revenue ($M) Sales (kg & kg equiv.) 21.7 22.8 2,528 2,330 17.6 2,020 14.7 15.9 1,740 1,830 Q417 Q118 Q218 Q318 Q418 Q417 Q118 Q218 Q318 Q418 Avg. Sales Price per Gram Patients (1000) 74 69 $8.43 59 64 $8.30 55 $8.03 $7.99 29 $7.96 Q4 17 Q1 18 Q218 Q318 Q418 Q317 Q417 Q118 Q218